Alpha-fetoprotein and Fanconi Anemia: Relevance to DNA Repair and Breast Cancer Susceptibility

References

• Mizejewski GJ. The phylogeny of alpha-fetoprotein in vertebrates: survey of biochemical and physiological data. Crit Rev Eukaryot Gene Expr. 1995;5(3–4):281–316.
   PubMed Web of Science ®Google Scholar
• Naidu S, Peterson ML, Spear BT. Alpha-fetoprotein related gene (ARG): a new member of the albumin gene family that is no longer functional in primates. Gene 2010;449(1–2):95–02.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Alpha-fetoprotein structure and function: relevance to isoforms, epitopes, and conformational variants. Exp Biol Med (Maywood). 2001;226(5):377–408.
   PubMed Web of Science ®Google Scholar
• Morinaga T, Sakai M, Wegmann TG, Tamaoki T. Primary structures of human alpha-fetoprotein and its mRNA. Proc Natl Acad Sci U S A. 1983;80(15):4604–8.
   PubMed Web of Science ®Google Scholar
• Luft AJ, Lorscheider FL. Structural analysis of human and bovine alpha-fetoprotein by electron microscopy, image processing, and circular dichroism. Biochemistry. 1983;22(25):5978–81.
   PubMed Web of Science ®Google Scholar
• Strop P, Zizkovsky V, Korcakova J, Havranova M, Mikes F. Conformational transitions of human alpha-1 fetoprotein and serum albumin at acid and alkaline pH. Int J Biochem. 1984;16(7):805–13.
   PubMedGoogle Scholar
• Mizejewski GJ. Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome. Exp Biol Med (Maywood). 2007;232(8):993–1004.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Alpha-fetoprotein as a biologic response modifier: relevance to domain and subdomain structure. Proc Soc Exp Biol Med. 1997;215(4):333–62.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Review of the adenocarcinoma cell surface receptor for human alpha-fetoprotein; proposed identification of a widespread mucin as the tumor cell receptor. Tumour Biol. 2013;34(3):1317–36.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. The alpha-fetoprotein third domain receptor binding fragment: in search of scavenger and associated receptor targets. J Drug Target. 2015;23:538–51.
   PubMed Web of Science ®Google Scholar
• Aussel C, Masseyeff R. Interaction of retinoids and bilirubin with the binding of arachidonic acid to human alpha-fetoprotein. Biochem Biophys Res Commun 1984;119(3):1122–27.
   PubMed Web of Science ®Google Scholar
• Benassayag C, Savu L, Vallette G, Delorme J, Nunez EA. Relations between fatty acids and oestrogen binding properties of pure rat alpha 1-foetoprotein. Biochim Biophys Acta 1979;587(2):227–37.
   PubMed Web of Science ®Google Scholar
• Sell S, Skelly H. Tissue sites of alpha fetoprotein synthesis by the rat during pregnancy and hepatoma growth. J Natl Cancer Inst. 1976;56(3):645–8.
   PubMedGoogle Scholar
• Kuo MT, Iyer B, Wu JR, Lapeyre JN, Becker FF. Methylation of the alpha-fetoprotein gene in productive and nonproductive rat hepatocellular carcinomas. Cancer Res. 1984;44(4):1642–7.
   PubMed Web of Science ®Google Scholar
• Mizejewski G. Alpha-Fetoprotein as a biomarker in immunodeficiency diseases: relevance to ataxia telangiectasia and related disorders, immunodiagnostics. J Immunodefic Disor 2014;3(1).
   PubMedGoogle Scholar
• Sell S. Heterogeneity of alpha-fetoprotein(AFP) and albumin containing cells in normal and pathological permissive states for AFP production: AFP containing cells induced in adult rats recapitulate the appearance of AFP containing hepatocytes in fetal rats. Oncodev Biol Med. 1980;1(2):93–105.
   PubMedGoogle Scholar
• Sell S, Skelly H, Leffert HL, Muller-Eberhard U, Kida S. Relationship of the biosynthesis of alpha-fetoprotein, albumin, hemopexin, and haptoglobin to the growth state of fetal rat hepatocyte cultures. Ann N Y Acad Sci. 1975;259:45–58.
   PubMed Web of Science ®Google Scholar
• Bei R, Mizejewski GJ. Alpha fetoprotein is more than a hepatocellular cancer biomarker: from spontaneous immune response in cancer patients to the development of an AFP-based cancer vaccine. Curr Mol Med. 2011;11(7):564–81.
   PubMed Web of Science ®Google Scholar
• Han SJ, Yoo S, Choi SH, Hwang EH. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors. Pediatr Surg Int. 1997;12(8):599–602.
   PubMed Web of Science ®Google Scholar
• Walhof CM, Van Sonderen L, Voute PA, Delemarre JF. Half-life of alpha-fetoprotein in patients with a teratoma, endodermal sinus tumor, or hepatoblastoma. Pediatr Hematol Oncol. 1988;5(3):217–27.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ, Bellisario R, Carter TP. Birth weight and alpha-fetoprotein in the newborn. Pediatrics. 1984;73(5):736–7.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunol Immunother. 2009;58(2):159–70.
   PubMed Web of Science ®Google Scholar
• Mizejewski GJ. Biological role of alpha-fetoprotein in cancer: prospects for anticancer therapy. Expert Rev Anticancer Ther. 2002;2(6):709–35.
   PubMedGoogle Scholar
• Mizejewski GJ. Alpha-Fetoprotein (AFP) and Inflammation: Is AFP an Acute and/or Chronic Phase Reactant? J Hematol Thrombo Dis. 2015;3(1).
   Google Scholar
• Alter BP, Kupfer G. Fanconi Anemia. Seattle (WA): University of Washington2013. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1401/.
   Google Scholar
• Risitano AM, Marotta S, Calzone R, Grimaldi F, Zatterale A, all RC. Twenty years of the Italian fanconi anemia registry: where we stand and what remains to be learned. Haematologica. 2016;101(3):319–27.
   PubMed Web of Science ®Google Scholar
• D'Andrea AD. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med. 2010;362(20):1909–19.
   PubMed Web of Science ®Google Scholar
• Fanconi G. Familial constitutional panmyelocytopathy, Fanconi's anemia (F.A.). I. Clinical aspects. Semin Hematol. 1967;4(3):233–40.
   Google Scholar
• Alter BP. Fanconi's anaemia and its variability. Br J Haematol. 1993;85(1):9–14.
   PubMed Web of Science ®Google Scholar
• Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood. 1989;73(2):391–6.
   PubMed Web of Science ®Google Scholar
• Shimamura A, Alter BP. Pathophysiology and management of inherited bone marrow failure syndromes. Blood Rev. 2010;24(3):101–22.
   PubMed Web of Science ®Google Scholar
• Alter BP. Cancer in Fanconianemia, 1927–2001. Cancer 2003;97(2):425–40.
   PubMed Web of Science ®Google Scholar
• Masserot-Lureau C, Adoui N, Degos F, de Bazelaire C, Soulier J, Chevret S, et al. Incidence of liver abnormalities in Fanconi anemia patients. Am J Hematol 2012;87(5):547–9.
   PubMed Web of Science ®Google Scholar
• Swift M, Caldwell RJ, Chase C. Reassessment of cancer predisposition of Fanconi anemia heterozygotes. J Natl Cancer Inst. 1980;65(5):863–7.
   PubMedGoogle Scholar
• Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab. 2007;92(7):2624–31.
   PubMed Web of Science ®Google Scholar
• Young NS, Alter BP. Clinical features of Fanconi anemia. In: Young NS, Alter BP, editors. Aplastic Anemia: Acquired and Inherited. Philadelphia: W.B. Saunders; 1994. p. 275–309.
   Google Scholar
• Porteous ME, Cross I, Burn J. VACTERL with hydrocephalus: one end of the Fanconi anemia spectrum of anomalies? Am J Med Genet. 1992;43(6):1032–4.
   PubMed Web of Science ®Google Scholar
• Parikh TB, Udani RH, Nanavati RN, Rao B. Fanconi's anemia in newborn. Indian Pediatr. 2005;42(3):285–7.
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101(3):822–6.
   PubMed Web of Science ®Google Scholar
• Niedernhofer LJ, Lalai AS, Hoeijmakers JH. Fanconi anemia (cross)linked to DNA repair. Cell. 2005;123(7):1191–8.
   PubMed Web of Science ®Google Scholar
• Carrington D, Gilmore DH, Whittle MJ, Aitken D, Gibson AA, Patrick WJ, et al. Maternal serum alpha-fetoprotein—a marker of fetal aplastic crisis during intrauterine human parvovirus infection. Lancet. 1987;1(8530):433–5.
   PubMed Web of Science ®Google Scholar
• Cassinat B, Guardiola P, Chevret S, Schlageter MH, Toubert ME, Rain JD, et al. Constitutive elevation of serum alpha-fetoprotein in Fanconi anemia. Blood. 2000;96(3):859–63.
   PubMed Web of Science ®Google Scholar
• Cassinat B, Darsin D, Guardiola P, Toubert ME, Rain JD, Gluckman E, et al. Intermethod discordance for alpha-fetoprotein measurements in Fanconi anemia. Clin Chem. 2001;47(8):1405–9.
   PubMed Web of Science ®Google Scholar
• Aslan D, Gumruk F, Alikasifoglu M, Altay C. Serum alpha-fetoprotein level in Fanconi's anemia: evaluation of 33 Turkish patients. Am J Hematol. 2002;71(4):275–8.
   PubMed Web of Science ®Google Scholar
• Fujii M, Uchino H. Elevation of serum alpha-fetoprotein in anemic patients. Clin Chim Acta. 1981;113(1):7–11.
   PubMed Web of Science ®Google Scholar
• Kubota H, Storms RW, Reid LM. Variant forms of alpha-fetoprotein transcripts expressed in human hematopoietic progenitors. Implications for their developmental potential towards endoderm. J Biol Chem. 2002;277(31):27629–35.
   PubMed Web of Science ®Google Scholar
• Chen Q, Khoury M, Limmon G, Choolani M, Chan JK, Chen J. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells. Stem Cells. 2013;31(6):1160–9.
   PubMed Web of Science ®Google Scholar
• Aselmann H, Wolfes H, Rohde F, Frerker M, Deiwick A, Jager MD, et al. Quantification of alpha 1-fetoprotein mRNA in peripheral blood and bone marrow: a tool for perioperative evaluation of patients with hepatocellular carcinoma. Langenbecks Arch Surg. 2001;386(2):118–23.
   PubMed Web of Science ®Google Scholar
• Zhao WJ, Chen YJ, Zhao ZG, Liu W, Liu SR, Sun QG, et al. A study of AFP and ALB expression in human mesenchymal stem cells induced by hepatopathy patient serum. Zhonghua Gan Zang Bing Za Zhi. 2006;14(4):300–1.
   PubMedGoogle Scholar
• Chou S, Lodish HF. Fetal liver hepatic progenitors are supportive stromal cells for hematopoietic stem cells. Proc Natl Acad Sci U S A. 2010;107(17):7799–804.
   PubMed Web of Science ®Google Scholar
• Hu WH, Ren J. Impact of hepatitis B virus infected serum on the hepatic differentiation of human bone marrow mesenchymal stem cells. Beijing Da XueXueBao. 2008;40(5):459–64.
   Google Scholar
• Li J, Tao R, Wu W, Cao H, Xin J, Guo J, et al. Transcriptional profiling and hepatogenic potential of acute hepatic failure-derived bone marrow mesenchymal stem cells. Differentiation. 2010;80(2–3):166–74.
   PubMed Web of Science ®Google Scholar
• Hunter WR. Measurement of optical properties of materials in the vacuum ultraviolet spectral region. Appl Opt. 1982;21(12):2103–14.
   PubMed Web of Science ®Google Scholar
• Kong FD, Pan MX, Wang HL, Shan YQ, Gao Y. Induced differentiation of bone marrow stem cells in transplanted rat liver. Nan Fang Yi Ke Da Xue Xue Bao 2007;27(4):468–70.
   PubMedGoogle Scholar
• Schwartz RE, Reyes M, Koodie L, Jiang Y, Blackstad M, Lund T, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109(10):1291–302.
   PubMed Web of Science ®Google Scholar
• Kang XQ, Zang WJ, Song TS, Xu XL, Yu XJ, Li DL, et al. Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. World J Gastroenterol. 2005;11(22):3479–84.
   PubMed Web of Science ®Google Scholar
• Huuskonen V, Hughes JM, EstacaBanon E, West E. Intratesticular lidocaine reduces the response to surgical castration in dogs. Vet Anaesth Analg 2013;40(1):74–82.
   PubMed Web of Science ®Google Scholar
• Kasahara T, Hara N, Bilim V, Tomita Y, Saito K, Obara K, et al. Sequential detection of alphafetoprotein-bearing cells in blood stem cell fraction of germ cell tumour patients. Br J Cancer. 2001;85(8):1119–23.
   PubMed Web of Science ®Google Scholar
• Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology. 2003;37(3):632–40.
   PubMed Web of Science ®Google Scholar
• Vasanthakumar A, Arnovitz S, Marquez R, Lepore J, Rafidi G, Asom A, et al. Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice. Blood. 2016;127(3):310–3.
   PubMed Web of Science ®Google Scholar
• Schwab RA, Nieminuszczy J, Shah F, Langton J, Lopez Martinez D, Liang CC, et al. The fanconi anemia pathway maintains genome stability by coordinating replication and transcription. Mol Cell. 2015;60(3):351–61.
   PubMed Web of Science ®Google Scholar
• Auerbach AD. Diagnosis of Fanconi anemia by diepoxybutane analysis. Curr Protoc Hum Genet. 2003;8(8.7): 1–17.
   Google Scholar
• Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2001;2(6):446–57.
   PubMed Web of Science ®Google Scholar
• Wang W. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007;8(10):735–48.
   PubMed Web of Science ®Google Scholar
• Lukas J, Lukas C, Bartek J. Mammalian cell cycle checkpoints: signaling pathways and their organization in space and time. DNA Repair (Amst). 2004;3(8–9):997–1007.
   PubMed Web of Science ®Google Scholar
• Garcia MJ, Benitez J. The Fanconianaemia/BRCA pathway and cancer susceptibility. Searching for new therapeutic targets. Clin Transl Oncol. 2008;10(2):78–84.
   PubMed Web of Science ®Google Scholar
• Rodriguez A, Torres L, Juarez U, Sosa D, Azpeitia E, Garcia-de Teresa B, et al. Fanconi anemia cells with unrepaired DNA damage activate components of the checkpoint recovery process. Theor Biol Med Model. 2015;12:19–25.
   Web of Science ®Google Scholar
• Venkitaraman AR. Connecting Fanconi's anaemia to breast cancer predisposition. Lancet. 2002;360(9343):1344–5.
   PubMed Web of Science ®Google Scholar
• Grompe M, van de Vrugt H. The Fanconi family adds a fraternal twin. Dev Cell. 2007;12(5):661–2.
   PubMed Web of Science ®Google Scholar
• Levy-Lahad E. Fanconi anemia and breast cancer susceptibility meet again. Nat Genet. 2010;42(5):368–9.
   PubMed Web of Science ®Google Scholar
• Auerbach A. Diagnosis of diseases of DNA synthesis and repair that affect the skin using cultured amniotic fluid cells. Semin Dermatology. 1984;3:172–84.
   Google Scholar
• Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72(5):1117–30.
   PubMed Web of Science ®Google Scholar
• Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol. 2007;25(11):1329–33.
   PubMed Web of Science ®Google Scholar
• Howlett NG, Taniguchi T, Olson S, Cox B, Waisfisz Q, De Die-Smulders C, et al. Biallelic inactivation of BRCA2 in Fanconi anemia. Science 2002;297(5581):606–9.
   PubMed Web of Science ®Google Scholar
• Patel KJ, Yu VP, Lee H, Corcoran A, Thistlethwaite FC, Evans MJ, et al. Involvement of Brca2 in DNA repair. Mol Cell. 1998;1(3):347–57.
   PubMed Web of Science ®Google Scholar
• Offit K, Levran O, Mullaney B, Mah K, Nafa K, Batish SD, et al. Shared genetic susceptibility to breast cancer, brain tumors, and Fanconi anemia. J Natl Cancer Inst. 2003;95(20):1548–51.
   PubMedGoogle Scholar
• Rebbeck TR. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers. Eur J Cancer. 2002;38 Suppl 6(S15–7.
   PubMed Web of Science ®Google Scholar
• Berwick M, Satagopan JM, Ben-Porat L, Carlson A, Mah K, Henry R, et al. Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res. 2007;67(19):9591–6.
   PubMed Web of Science ®Google Scholar
• Venkitaraman AR. Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell. 2002;108(2):171–82.
   PubMed Web of Science ®Google Scholar
• Zhu W, Dutta A. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication. Mol Cell Biol. 2006;26(12):4601–11.
   PubMed Web of Science ®Google Scholar
• Draga M, Madgett EB, Vandenberg CJ, du Plessis D, Kaufmann A, Werler P, et al. BRCA1 Is Required for Maintenance of Phospho-Chk1 and G2/M Arrest during DNA Cross-Link Repair in DT40 Cells. Mol Cell Biol. 2015;35(22):3829–40.
   PubMed Web of Science ®Google Scholar